You are here

  • Home
  • Archive
  • Volume 12, Issue 11
  • Safety and efficacy of ticagrelor as single antiplatelet therapy in prevention of thromboembolic complications associated with the Pipeline Embolization Device (PED): multicenter experience

Article metrics

Article menu
Download PDFPDF
Hemorrhagic Stroke
Original research
Safety and efficacy of ticagrelor as single antiplatelet therapy in prevention of thromboembolic complications associated with the Pipeline Embolization Device (PED): multicenter experience

 

Online download statistics by month:

Online download statistics by month: May 2020 to July 2022

AbstractFullPdf
May 2020595209
Jun 202012177433
Jul 20202551813
Aug 202010266
Sep 20201161210
Oct 20203803821
Nov 20201842615
Dec 2020160139
Jan 2021115146
Feb 20211301214
Mar 2021123147
Apr 20211472926
May 202150166
Jun 20211085
Jul 20211255
Aug 20211387
Sep 20211883
Oct 202173335
Nov 202110542
Dec 20214742
Jan 202283102
Feb 20225353
Mar 20229563
Apr 202293166
May 20229553
Jun 202210473
Jul 20227255
Total4447416229